-
Identifying Risk Factors Associated With Meningioma: A Systematic Review
Sep 9, 2025, 16:22 PM -
Self-Reported Health Related Quality of Life (HRQoL) in Patients With Ischemic Heart Disease: A Randomized Controlled Trial on Digital Health Pharmacist Interventions
Sep 9, 2025, 16:22 PM -
From Pain to Patient Preferences Patient Engagement in Early HTA for Repurposing Losartan in Osteogenesis Imperfecta
Sep 9, 2025, 16:22 PM -
Efficacy and Safety of Inhaled Levofloxacin vs. Other Inhaled Antibiotics in the Treatment of Adults With Cystic Fibrosis and Chronic Pseudomonas Aeruginosa Lung Infection: An Updated Network Meta-Analysis
Sep 9, 2025, 16:22 PM -
The Impact of Burosumab on the Clinical and Economic Burden of X-Linked Hypophosphatemia in Adult Patients in France
Sep 9, 2025, 16:22 PM -
Therapeutic Drug Monitoring and Selective Use of Glucarpidase in High-Dose Methotrexate Therapy: A Cost Analysis From the Algerian Payer Perspective
Sep 9, 2025, 16:22 PM -
Modeling Intelligence Quotient (IQ) Changes Relative to Blood Phe Levels in Individuals With Phenylketonuria (PKU) Treated With Sepiapterin and Sapropterin Dihydrochloride
Sep 9, 2025, 16:22 PM -
Efficacy and Safety of Biologics to Treat Adults With Active Radiographic Axial Spondyloarthritis: Systematic Review and Bayesian Network Meta-Analysis
Sep 9, 2025, 16:22 PM -
Using External Clinical Evidence to Inform Local Health Policy: The Tradeoff Between Early Access and Uncertainty
Sep 9, 2025, 16:22 PM -
A Budget Impact Analysis of Exclusive Human Milk Diet in Very Low Birth Weight Infants in Sheikh Shakhbout Medical City
Sep 9, 2025, 16:22 PM -
The Rapid Involvement of Patients and the Public in Evidence Synthesis (RIPPLES) Framework: Development and Guidance
Sep 9, 2025, 16:22 PM -
Modeling the Future Clinical and Environmental Burden of Chronic Kidney Disease in Ghana and Uganda Between 2025 and 2030
Sep 9, 2025, 16:22 PM -
Potential Impacts of Improvement in Turnaround Time
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness of Mixed Maternal RSVpreF/Infant Nirsevimab Immunization Approach vs. Nirsevimab Alone for the Prevention of Respiratory Syncytial Virus in Chile
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness Analysis of CYP2C19 Genotype-Guided Antiplatelet Therapy for Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention in the Netherlands
Sep 9, 2025, 16:22 PM -
Estimating the Incidence and Prevalence of Menorrhagia in the UK Using the THIN Database
Sep 9, 2025, 16:22 PM -
Nutrieconomics: Concept and Expert Consensus on Health Technology Assessment of Nutritional Interventions in Brazil
Sep 9, 2025, 16:22 PM -
Does Modeling Adherence Matter? Insights From Prior NICE Appraisals
Sep 9, 2025, 16:22 PM -
HTA Submission Trends for EMA-Approved Oncology NASs Prior to the EU HTA Regulation 2018-2023
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness Analysis of Oral Semaglutide As a Third-Line Treatment for Patients With Type 2 Diabetes Mellitus
Sep 9, 2025, 16:22 PM
